MicroPort NeuroScientific

MicroPort NeuroScientific is a global medical technology company focused on neuro-interventional devices for cerebrovascular diseases, particularly in stroke treatment. Established in 2012 and publicly listed in 2022, it operates as a subsidiary of MicroPort® Scientific, which is based in Shanghai, China. The company aims to enhance the lives of stroke patients by providing accessible and high-quality solutions. Their product range includes devices such as the Tubridge Flow-diverting Stent, Fastrack Microcatheter System, and WILLIS Intracranial Stent Graft, designed to address complex neurovascular conditions. In addition to these devices, MicroPort NeuroScientific offers integrated solutions that encompass surgical training, clinical support, and postoperative follow-ups, ensuring optimal patient outcomes. With a presence in over 3,300 hospitals in China and marketing approvals for nine products across 23 countries, the company is committed to innovation and quality. MicroPort NeuroScientific holds over 196 patents and facilitates numerous cerebrovascular procedures daily, reflecting its dedication to advancing neurovascular care in partnership with healthcare professionals.

• Employees27